EMEA-001149-PIP01-11-M07 - paediatric investigation plan
human fibrinogen
human thrombin
PIPHuman
Omrix Biopharmaceuticals N.V.
Email: DL-OMRilRAAllStaff@ITS.JNJ.com
Tel. +32 27463000
P/0397/2021 : EMA decision of 8 September 2021 on the acceptance of a modification of an agreed paediatric investigation plan for human fibrinogen / human thrombin (Evicel, Evarrest), (EMEA-001149-PIP01-11-M07)